The health funds are buying the waiting room.

What happened

Three health deals, one direction of travel: private health insurers want to own the front door of the health system, and the market wants listed acquirers to stay close to home.

• Bupa / Partnered Health. Bupa has agreed to buy Partnered Health Group from funds managed or advised by Quadrant Private Equity. Partnered runs 68 primary care clinics, three urgent care clinics and five corporate health and wellbeing brands. Bupa didn't disclose a price; the AFR's Street Talk reported about $450 million. The deal needs ACCC and FIRB approval.
• Medibank / Better Medical. The template. Medibank agreed in November to buy Better Medical, 61 GP and medical clinics across Victoria, Queensland, South Australia and Tasmania, from Livingbridge for about $159 million. It completed on 16 December and now sits in Medibank's Amplar Health network.
• Sigma / Boots. Sigma Healthcare, owner of Chemist Warehouse, confirmed on 10 June that it was in preliminary talks on Boots, the UK health and beauty chain, in a deal the Financial Times put at about US$10 billion. On 15 June it walked away, saying a deal would not meet its "strategic and capital investment objectives".

The insurers' land grab

Bupa runs 32 medical centres today, plus 13 Mindplace mental health clinics. Partnered takes it to about 100 medical centres, and the urgent care clinics give it a service it doesn't currently offer. In May last year Bupa set a target of 130 medical centres by 2028. This deal gets it most of the way in one step.

Medibank is further ahead. Medical Republic counts about 170 sites in its Amplar Health network, the largest GP group on its list. On Medical Republic's numbers, if Bupa's deal is approved, insurers will run about three in every 20 group GP clinics in the country.

Why insurers want clinics isn't complicated. "We know when people get care earlier, health outcomes improve and costs fall," said Bupa's Asia Pacific chief executive, Nick Stone. Insurers are largely kept out of GP funding under current rules, so owning the clinic is the way in. Both buyers have been careful to promise doctors their independence. Better Medical said its GPs "will continue to have full clinical autonomy and will continue to set their fees independently".

The one that got away

Sigma's Boots flirtation lasted five days, and the market voted both times. The shares fell as much as 5.5% the day Sigma confirmed the talks and rose as much as 8.3% the day it walked away. "Investors appear to have breathed a sigh of relief," said Marc Jocum of Global X ETFs. Sigma said it "has many opportunities for growth" and is focused on Australia, with overseas expansion still a long-term pillar.

Walking away is a deal skill too. A board that can say no to a transformational deal, and be rewarded for it, has kept its discipline intact for the next one.

Not a new trick

Health and care roll-ups have a long history. Back in 2014, Australian Unity bought Sydney home care provider INS Health Care and its 126 home care packages to build out home care around its retirement villages. The cheques are bigger now. The logic is the same: own the relationship closest to the customer.

The mid-market read

Partnered's forecast EBITDA was reported at more than $40 million, which puts it squarely in the mid-market. And two private equity owners, Livingbridge and Quadrant, have now sold clinic platforms to insurers within seven months. For owners of healthcare services businesses, three things set the price:

1. The practitioners. Buyers pay for doctors who stay. Know how your clinicians are engaged, how long they are committed, and what happens to billings if two key people leave.
2. The structure. How doctors are contracted drives payroll tax and regulatory risk. Expect a buyer's diligence to start there.
3. The regulator. Bupa needs ACCC and FIRB approval, and since 1 January merger notification has been mandatory above the thresholds. A roll-up should plan its clearances before it plans its next clinic.

What to watch

• The ACCC and FIRB reviews of Bupa–Partnered.
• Whether Medibank, with Better Medical bedded down, keeps buying.
• Who else bids for Boots.

Update, 26 October 2026: the ACCC cleared Bupa's acquisition of Partnered Health at phase 1 on 9 October.

General information only, not financial product advice. The Bupa–Partnered price is as reported by the AFR; Bupa has not disclosed it.